Cardiovascular Devices Market Analysis

  • Report ID: 3272
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT

Cardiovascular Devices Market Segmentation:

Application Segment Analysis

The coronary artery diseases segment is expected to hold largest market share by 2035. In CAD, the coronary arteries, the main blood channels feeding the heart, have difficulty supplying the heart muscle with adequate blood, oxygen, and nutrients, owing to inflammation and cholesterol deposits (plaques) in the major heart arteries. For instance, according to research, it is also a common cause of death in the US, and is estimated to cause over 600,000 deaths yearly, is responsible for 18 million deaths per year worldwide, and is the third biggest cause of mortality.

End User Segment Analysis

The hospital segment is expected to dominate largest market share by 2035, on the back of developed and advanced healthcare infrastructure, improved access to healthcare facilities, growing adoption of innovative healthcare devices, and the rising practice of sedentary lifestyle. Moreover, there has been an increase in the number of hospitals across the globe adopting advanced cardiovascular devices, which is expected to boost the segment growth.

Our in-depth analysis of the global cardiovascular devices market includes the following segments:

            By Device Type

  • Diagnostic and Monitoring Devices
  • Electrocardiogram
  • Remote Cardiac Monitoring
  • Others
  • Therapeutic and Surgical Devices
  • Ventricular Assist Devices (VAD)
  • Cardiac Rhythm Management Devices
  • Catheters

             By Application

  • Coronary Artery Diseases
  • Cardiac Arrhythmia
  • Heart Failure

             By End User

  • Hospitals
  • Specialty Clinics
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of cardiovascular devices is evaluated at USD 73.91 billion.

The global cardiovascular devices market size was worth over USD 69.06 billion in 2025 and is poised to grow at a CAGR of around 7.8%, reaching USD 146.36 billion revenue by 2035.

North America cardiovascular devices market will dominate over 40.8% share by 2035, driven by the rising prevalence of cardiovascular diseases and increasing healthcare expenditure.

Key players in the market include B Braun Melsungen AG, Abbott, Johnson & Johnson Services, Inc., Terumo Corporation, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, LivaNova PLC, GE Group, Siemens Healthcare GmbH.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos